Clinical trials
Technology clinical trials
Below are recruiting technology clinical trials, each written for real people, not researchers. We’re tracking 1,080 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07171255Recruiting
App-based exercise program for rural adults
This trial tests if a smartphone app can help adults aged 40-85 who are not very active, live in rural parts of Kansas or Nebraska, and are at risk for health problems. The goal is to see if using the app helps them exercise more and stick with it.
Emporia, KansasAges 40–85 - NCT07164885Recruiting
RAPART trial for advanced lung cancer patients
This trial tests a treatment for stage 3 lung cancer that cannot be removed with surgery. It includes people who have had other treatments before, like chemo or immunotherapy.
Shenzhen, GuangdongAges 18 years+ - NCT07166224Recruiting
Home treatments for gum disease in older adults with memory issues
This trial tests two simple ways to improve gum health at home: using a special light-activated antibacterial rinse or using a powered toothbrush. It's for older adults who have gum disease and mild memory problems, and aims to see if these easy routines can help keep gums healthier.
Karlskrona, Blekinge CountyAges 60 years+ - NCT07168382Recruiting
AI-Powered Self-Care for Caregivers of Children
This study tests an AI-powered tool that helps caregivers of children find personalized resources for social needs like food, housing, or transportation. You'll use a simple app to get support for yourself and your family.
Columbus, OhioAges Any age - NCT07162675Recruiting
Step count and treatment response in breast cancer patients
This study looks at how your daily step count, measured by a smartwatch, relates to how well your breast cancer responds to treatment before surgery. It may help show if being more active during chemotherapy leads to better outcomes.
Ankara, YenimahalleAges 18 years+ - NCT07162584Recruiting
Oxytocin and human defensive responses
This study looks at how oxytocin—a natural hormone—affects your body's defensive reactions in changing situations. It may help researchers understand how our brains handle fear and safety.
Chengdu, SichuanAges 18–35 - NCT07156253RecruitingPhase 1
Study of SYN818 with olaparib for advanced solid tumors
This trial is testing a new drug, SYN818, combined with olaparib for people with advanced solid tumors that have certain genetic changes (BRCA mutations or related DNA repair problems). It may be an option if you have ovarian or HER2-negative breast cancer and other treatments are no longer working.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07152717Recruiting
Smartphone pressure monitor for leg ulcer treatment
This trial tests a new pressure-monitoring technology that works with your smartphone to help improve compression therapy for venous leg ulcers. If you are already getting compression therapy for your leg ulcer, you may be able to join.
Fort Wayne, IndianaAges 18 years+ - NCT07145151RecruitingPhase 2
Studying UBT251 for MASH liver disease
This trial tests a new medication called UBT251 for people with MASH, a type of liver disease linked to weight and metabolism. It aims to see if the medicine can reduce liver damage and scarring.
Beijing, Beijing MunicipalityAges 18–75 - NCT07147049RecruitingPhase 2
Testing a new painkiller for moderate to severe pain after surgery
This trial tests a new tablet called HL-1186 for people with moderate to severe pain after certain surgeries. It aims to see if the drug is safe and works well for pain control.
Chengdu, SichuanAges 18–75 - NCT07146828Recruiting
High-precision vision test for laser eye surgery
This trial tests a very precise way to measure vision (0.05 diopter steps) for people getting SMILE laser eye surgery. The goal is to see if this fine-tuning leads to better results.
Nantong, JiangsuAges 18–40 - NCT07151885Recruiting
Using ultrasound and blood tests to predict varices risk in cirrhosis
This trial tests if a special ultrasound technique combined with liver stiffness and platelet count can predict which patients with cirrhosis have high-risk varices in the esophagus or stomach, potentially reducing the need for repeated endoscopy.
Changchun, JilinAges 18 years+ - NCT07149571Recruiting
New MRI for metabolic fatty liver disease
This study uses a new MRI technique to measure how metabolic fatty liver disease affects your body and to track your health over time. It aims to improve understanding of the condition and guide treatment.
Wuhan, HubeiAges Any age - NCT07154251Recruiting
Community health workers as diabetes tech coaches for kids
This trial tests whether a community health worker can help Black children with type 1 diabetes use their automated insulin delivery system (a combination of a continuous glucose monitor and an insulin pump) more effectively. Children who are already using or have used this system in the past 3 months may qualify.
Cleveland, OhioAges 5–17 - NCT06959628Recruiting
Study of a new shunt system for carotid artery blockage treatment
This trial tests a special shunt system to protect your brain during carotid artery stenting. It may help people with severe blockages in the neck artery that supplies blood to the brain.
BeijingAges 18 years+ - NCT06666829Recruiting
Personalized rehab with robotics for kids with developmental disabilities
This trial tests a personalized rehabilitation plan that uses new technology and robotic devices to help children and teens with developmental disabilities. The goal is to see if combining these tools can improve daily skills and quality of life.
Genova, GenovaAges 5–21 - NCT07142304Recruiting
A study of compression gloves and boots to prevent chemo nerve damage
This trial is testing a wearable device (gloves and boots) that applies gentle compression to your hands and feet during chemotherapy. It aims to prevent or reduce nerve damage (numbness, tingling, pain) that some chemotherapy drugs can cause.
Poway, CaliforniaAges 18 years+ - NCT07140237RecruitingEarly Phase 1
Can oxytocin improve attention?
This study tests if taking oxytocin (or a drug that blocks it) affects how well you pay attention. It helps researchers understand the role of oxytocin in focusing the mind.
Chengdu, SichuanAges 18–35 - NCT07139808Recruiting
A new glucose and ketone monitor for type 1 diabetes
This trial tests a new device that measures blood sugar and ketones continuously. It may help people with type 1 diabetes who use an insulin pump keep better track of their levels.
Shijiazhuang, HebeiAges 18 years+ - NCT07134335RecruitingPhase 2
Study of UBT251 injection for chronic kidney disease
This study tests an investigational injection called UBT251 for people with chronic kidney disease who are overweight. It aims to see if it can reduce protein in the urine and help protect kidney function.
BeijingAges 18–75 - NCT07131358Recruiting
Comparing cavity prevention methods in schoolchildren
This trial tests three different methods to prevent cavities in children's back teeth (first permanent molars). It's for kids ages 6 to 8 who are at risk for cavities and attend public schools in Nezahualcóyotl, Mexico.
Nezahualcóyotl, State of MexicoAges 6–8 - NCT07126496Recruiting
Virtual health educator for cancer trial referrals
This study tests a virtual community health educator to help cancer patients and their caregivers learn more about and join clinical trials. If you have had cancer or care for someone who has, this program might help you find trials that fit.
Jacksonville, FloridaAges 18 years+ - NCT07131215Recruiting
Smart technology for health in early menopause
This trial tests whether a smartphone-based program can help monitor and improve the physical and mental health of women who have recently gone through menopause. It aims to see if technology can support healthy lifestyle changes during this transition.
TainanAges 40–65 - NCT06932744RecruitingPhase 3
Testing a new PNH pill for people who haven't had complement therapy
This study tests a new oral medication called MY008211A for people with PNH who have not yet tried complement inhibitors. It aims to improve anemia and reduce the need for blood transfusions by targeting the part of the immune system that destroys red blood cells.
Beijing, Beijing MunicipalityAges 18–75
Hear when a new Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for technology?
- Yes. Clin2 currently lists 1,080 recruiting technology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a technology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a technology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.